Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 20, 2024Transplantation and Cellular TherapyOpen Access

Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy

View Full Paper
Ask AI
Bookmark
Share

Authors

RERebecca EpperlySt. Jude Children's Research HospitalYLYing LiSt. Jude Children's Research HospitalSSSubodh SelukarSt. Jude Children's Research Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Epperly et al. (2024) studied this question.

synapsesocial.com/papers/68e786f9b6db6435876f984bhttps://doi.org/10.1016/j.jtct.2024.02.016
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Outcome of relapse after allogeneic <scp>HSCT</scp> in children with <scp>ALL</scp> enrolled in the <scp>ALL</scp>‐<scp>SCT</scp> 2003/2007 trial2017 · 77 citations
  2. 2Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies2016 · 73 citations
  3. 3National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report2014 · 5,476 citations
  4. 4Role of a second transplantation for children with acute leukemia following posttransplantation relapse: a study by the Turkish Bone Marrow Transplantation Study Group2020 · 6 citations
  5. 5Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults2020 · 73 citations